## **Core Concept**
Gastrointestinal stromal tumors (GISTs) are a type of tumor that occurs in the digestive tract, most commonly in the stomach or small intestine. They originate from the interstitial cells of Cajal or their precursors. GISTs are known for their specific molecular markers.

## **Why the Correct Answer is Right**
The correct answer, **CD117 (c-KIT)**, is a receptor tyrosine kinase. A significant majority of GISTs have mutations in the KIT gene or the PDGFRA gene, leading to the overexpression of these receptor tyrosine kinases. **CD117 (c-KIT)** is considered a specific marker for GIST because it is positive in about 95% of these tumors, making it a crucial diagnostic tool.

## **Why Each Wrong Option is Incorrect**
- **Option A: CD34** - While CD34 is a marker that can be positive in GISTs, it is not specific for GISTs as it can also be found in other types of tumors and normal hematopoietic progenitor cells.
- **Option B: S-100** - S-100 is a marker more commonly associated with neural crest-derived tumors, such as melanomas and schwannomas, not specifically with GISTs.
- **Option D: SMA (Smooth Muscle Actin)** - SMA is a marker for smooth muscle cells and can be positive in leiomyomas and leiomyosarcomas, which are different from GISTs.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of **CD117 (c-KIT)** positivity is highly suggestive of GIST, and mutations in the KIT or PDGFRA genes are found in the majority of GIST cases. This information is crucial for targeted therapy, as GISTs responsive to tyrosine kinase inhibitors like imatinib often have these mutations.

## **Correct Answer:** . CD117 (c-KIT)